{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:07:04Z","timestamp":1791655624632,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801546"],"award-info":[{"award-number":["81801546"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","award":["shslczdzk06502"],"award-info":[{"award-number":["shslczdzk06502"]}],"id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","award":["FudanX24AI065"],"award-info":[{"award-number":["FudanX24AI065"]}],"id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014175","name":"Shanghai Municipal Health and Family Planning Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008410","name":"Shanghai Municipal Population and Family Planning Commission","doi-asserted-by":"publisher","award":["2016ZB0301-01"],"award-info":[{"award-number":["2016ZB0301-01"]}],"id":[{"id":"10.13039\/501100008410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejps.2025.107241","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T20:53:56Z","timestamp":1755809636000},"page":"107241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Towards model-informed precision dosing of cyclosporine in adult renal transplantation: Assessing population pharmacokinetic models and multi-model strategies"],"prefix":"10.1016","volume":"214","author":[{"given":"Feiyan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4219-5953","authenticated-orcid":false,"given":"Junjun","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeneng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107241_bib0001","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/jcph.1670","article-title":"Population pharmacokinetic modeling of cyclosporine among Malaysian renal transplant patients: an evaluation of methods to handle missing doses in conventional drug-monitoring data","volume":"60","author":"Albitar","year":"2020","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107241_bib0002","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/FTD.0b013e3181d3f822","article-title":"Computer-assisted cyclosporine dosing performs better than traditional dosing in renal transplant recipients: results of a pilot study","volume":"32","author":"Asberg","year":"2010","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.ejps.2025.107241_bib0003","first-page":"2241","article-title":"Early non-steady-state population pharmacokinetics of oral cyclosporine in renal transplant recipients","volume":"8","author":"Baek","year":"2014","journal-title":"Drug. Des. Devel. Ther."},{"key":"10.1016\/j.ejps.2025.107241_bib0004","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/fcp.12591","article-title":"Food and lipid intake alters the pharmacokinetics of cyclosporine in kidney transplants","volume":"35","author":"Bennani Rtel","year":"2021","journal-title":"Fundam Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107241_bib0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2125.2005.02200.x","article-title":"Bayesian estimation of cyclosporin exposure for routine therapeutic drug monitoring in kidney transplant patients","volume":"59","author":"Bourgoin","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107241_bib0006","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1208\/s12248-018-0205-x","article-title":"Comparison of model averaging and model selection in dose finding trials analyzed by nonlinear mixed effect models","volume":"20","author":"Buatois","year":"2018","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2025.107241_bib0007","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00228-010-0959-2","article-title":"Population pharmacokinetic study of cyclosporine in Chinese renal transplant recipients","volume":"67","author":"Chen","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107241_bib0008","first-page":"493","article-title":"Cyclosporine in transplantation - a history of converging timelines","volume":"25","author":"Colombo","year":"2011","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.ejps.2025.107241_bib0009","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s40262-023-01233-7","article-title":"External evaluation of population pharmacokinetic models for precision dosing: current State and knowledge gaps","volume":"62","author":"El Hassani","year":"2023","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2025.107241_bib0010","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2165\/00003088-199324060-00004","article-title":"Cyclosporin clinical pharmacokinetics","volume":"24","author":"Fahr","year":"1993","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2025.107241_bib0011","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/00007691-199312000-00006","article-title":"Area-under-the-curve versus trough level monitoring of cyclosporine concentration: critical assessment of dosage adjustment practices and measurement of clinical outcome","volume":"15","author":"Grevel","year":"1993","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.ejps.2025.107241_bib0012","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00007691-199512000-00013","article-title":"Challenges in cyclosporine therapy: the role of therapeutic monitoring by area under the curve monitoring","volume":"17","author":"Kahan","year":"1995","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.ejps.2025.107241_bib0013","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/psp4.12813","article-title":"Multi-model averaging improves the performance of model-guided infliximab dosing in patients with inflammatory bowel diseases","volume":"11","author":"Kantasiripitak","year":"2022","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107241_bib0014","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/ejh.13674","article-title":"TRough versus AUC monitoring of cyclosporine: a randomized comparison of adverse drug reactions in adult allogeneic stem cell recipients (TRAM study)","volume":"107","author":"Kuijvenhoven","year":"2021","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.ejps.2025.107241_bib0015","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/01.tp.0000203306.72858.df","article-title":"Early cyclosporine C0 and C2 monitoring in de novo kidney transplant patients: a prospective randomized single-center pilot study","volume":"81","author":"Kyllonen","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.ejps.2025.107241_bib0016","doi-asserted-by":"crossref","first-page":"311","DOI":"10.5125\/jkaoms.2023.49.6.311","article-title":"Review of two immunosuppressants: tacrolimus and cyclosporine","volume":"49","author":"Lee","year":"2023","journal-title":"J. Korean Assoc. Oral Maxillofac. Surg."},{"key":"10.1016\/j.ejps.2025.107241_bib0017","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10928-025-09967-6","article-title":"Sampling from covariate distribution may not always be necessary in PK\/PD simulations: illustrative examples with antibiotics","volume":"52","author":"Liu","year":"2025","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.ejps.2025.107241_bib0018","doi-asserted-by":"crossref","first-page":"107S","DOI":"10.1016\/j.transproceed.2004.01.064","article-title":"Use of cyclosporine in renal transplantation","volume":"36","author":"Lloveras","year":"2004","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ejps.2025.107241_bib0019","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2710.2005.00683.x","article-title":"Time-dependent pharmacokinetics of cyclosporine (Neoral) in de novo renal transplant patients","volume":"30","author":"Lukas","year":"2005","journal-title":"J. Clin. Pharm Ther."},{"key":"10.1016\/j.ejps.2025.107241_bib0020","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s11095-021-03114-9","article-title":"Factors affecting time-varying clearance of cyclosporine in adult renal transplant recipients: a population pharmacokinetic perspective","volume":"38","author":"Mao","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107241_bib0021","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/bcp.13431","article-title":"External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipients","volume":"84","author":"Mao","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107241_bib0022","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/01.TP.0000085046.39523.D5","article-title":"C2 monitoring in maintenance renal transplant recipients: is it worthwhile?","volume":"76","author":"Midtvedt","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.ejps.2025.107241_bib0023","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00007691-200004000-00003","article-title":"Cyclosporin assays, metabolite cross-reactivity, and pharmacokinetic monitoring","volume":"22","author":"Morris","year":"2000","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.ejps.2025.107241_bib0024","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00228-017-2279-2","article-title":"Population pharmacokinetics of cyclosporine A in Japanese renal transplant patients: comprehensive analysis in a single center","volume":"73","author":"Okada","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107241_bib0025","doi-asserted-by":"crossref","first-page":"404S","DOI":"10.1016\/j.transproceed.2003.12.045","article-title":"Pharmacologic monitoring and outcomes of cyclosporine","volume":"36","author":"Pollard","year":"2004","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ejps.2025.107241_bib0026","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00228-010-0810-9","article-title":"Explaining variability in ciclosporin exposure in adult kidney transplant recipients","volume":"66","author":"Press","year":"2010","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107241_bib0027","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00003088-198611020-00002","article-title":"Clinical pharmacokinetics of cyclosporin","volume":"11","author":"Ptachcinski","year":"1986","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2025.107241_bib0028","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2165\/00003088-200645090-00003","article-title":"Patient characteristics influencing ciclosporin pharmacokinetics and accurate Bayesian estimation of ciclosporin exposure in heart, lung and kidney transplant patients","volume":"45","author":"Saint-Marcoux","year":"2006","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2025.107241_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107305","article-title":"Predictive performance of multi-model approaches for model-informed precision dosing of piperacillin in critically ill patients","volume":"64","author":"Schatz","year":"2024","journal-title":"Int. J. Antimicrob. Agent."},{"key":"10.1016\/j.ejps.2025.107241_bib0030","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1345\/aph.1R004","article-title":"CYP3A5 polymorphism effect on cyclosporine pharmacokinetics in living donor renal transplant recipients: analysis by population pharmacokinetics","volume":"46","author":"Song","year":"2012","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejps.2025.107241_bib0031","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/01.TP.0000089006.00653.64","article-title":"Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion","volume":"76","author":"Thervet","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.ejps.2025.107241_bib0032","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00007691-200406000-00012","article-title":"Dose adjustment strategy for oral microemulsion formulation of cyclosporine: population pharmacokinetics-based analysis in kidney transplant patients","volume":"26","author":"Tokui","year":"2004","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.ejps.2025.107241_bib0033","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/cpt.2065","article-title":"A model averaging\/selection approach improves the predictive performance of model-informed precision dosing: vancomycin as a case study","volume":"109","author":"Uster","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2025.107241_bib0034","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1124\/dmd.105.004358","article-title":"Population pharmacokinetics of cyclosporine in clinical renal transplant patients","volume":"33","author":"Wu","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2025.107241_bib0035","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1016\/S0041-1345(01)02340-5","article-title":"Comparative study of population pharmacokinetics upon switching of cyclosporine formulation from Sandimmune to Neoral in stable renal transplant patients","volume":"33","author":"Yoshida","year":"2001","journal-title":"Transplant. Proc."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725002404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725002404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:57:57Z","timestamp":1778558277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725002404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":35,"alternative-id":["S0928098725002404"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107241","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards model-informed precision dosing of cyclosporine in adult renal transplantation: Assessing population pharmacokinetic models and multi-model strategies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107241","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107241"}}